Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.5.4) was added to the study's version history, and the previous revision (v3.5.3) was removed from the list.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s displayed software revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor update to the ClinicalTrials.gov interface rather than a change to any trial record details.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a new revision (v3.5.0) to the Record History, replacing the previous v3.4.3 entry to reflect an updated study record.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check107 days agoChange DetectedRevision: v3.4.2 was added; the government-funding notice and the v3.4.1 entry were removed.SummaryDifference0.7%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.